14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ABEO
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Big movements in Abeona Therapeutics Inc. stock price on Wednesday moving 12.10% between high and low
(Updated on Apr 24, 2024)

Sell candidate since Apr 23, 2024 Loss -7.04% PDF

The Abeona Therapeutics Inc. stock price fell by -7.04% on the last day (Wednesday, 24th Apr 2024) from $3.41 to $3.17. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 12.10% from a day low at $3.14 to a day high of $3.52. The price has been going up and down for this period, and there has been a -56.93% loss for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -3 million shares and in total, 2 million shares were bought and sold for approximately $7.00 million.

Given the current short-term trend, the stock is expected to rise 29.74% during the next 3 months and, with a 90% probability hold a price between $4.11 and $12.88 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ABEO Signals & Forecast

There are few to no technical positive signals at the moment. The Abeona Therapeutics Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $6.39 and $7.45. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, March 06, 2024, and so far it has fallen -63.48%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Abeona Therapeutics Inc. stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.380 between high and low, or 12.10%. For the last week, the stock has had daily average volatility of 12.28%.

Abeona Therapeutics Inc. is oversold on RSI14 (15). Some stocks may fall long and hard while being oversold on RSI, but stocks that are heavily oversold on RSI often pose good re-bounce chance and played well it can be a buy candidate.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ABEO) For The Upcoming Trading Day Of Thursday 25th

For the upcoming trading day on Thursday, 25th we expect Abeona Therapeutics Inc. to open at $3.28, and during the day (based on 14 day Average True Range), to move between $2.42 and $3.92, which gives a possible trading interval of +/-$0.750 (+/-23.66%) up or down from last closing price. If Abeona Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 47.33% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $3.41, some $0.240 (7.57%) from the current price of $3.17, our system finds the risk reward not very attractive.

Is Abeona Therapeutics Inc. stock A Buy?

The Abeona Therapeutics Inc. stock holds several negative signals and despite the positive trend, we believe Abeona Therapeutics Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -3.406 Sell Candidate Unchanged

Predicted Opening Price for Abeona Therapeutics Inc. of Thursday, April 25, 2024

Fair opening price April 25, 2024 Current price
$3.28 ( 3.36%) $3.17

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ABEO

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 3.66 15.35 %
R2 3.51 10.77 %
R1 3.42 7.94 %
Current price: 3.17
Support S1 3.13 -1.21 %
S2 3.04 -4.04 %
S3 2.90 -8.62 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 0 .
R1 3.41 7.57 %
Current price 3.17
Support S1 0 .
S2 0 .
S3 0 .

ABEO Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Mar 31, 2000 Mar 31, 2000 Mar 31, 2000 $3,706.25 8.55%

FAQ

What is the symbol for Abeona Therapeutics Inc. Stock and on which exchange is it traded?
The symbol for Abeona Therapeutics Inc. is ABEO and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Abeona Therapeutics Inc. Stock?
The Abeona Therapeutics Inc. stock holds several negative signals and despite the positive trend, we believe Abeona Therapeutics Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Abeona Therapeutics Inc. Stock?
Abeona Therapeutics Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Abeona Therapeutics Inc. Stock.

What's the current price of Abeona Therapeutics Inc. Stock?
As of the end of day on the Apr 24, 2024, the price of an Abeona Therapeutics Inc. (ABEO) share was $3.17.

What is the 52-week high and low for Abeona Therapeutics Inc. Stock?
The 52-week high for Abeona Therapeutics Inc. Stock is $9.01 and the 52-week low is $2.85.

What is the market capitalization of Abeona Therapeutics Inc. Stock?
As of the Apr 24, 2024, the market capitalization of Abeona Therapeutics Inc. is 86.715M.

When is the next earnings date for Abeona Therapeutics Inc.?
The upcoming earnings date for Abeona Therapeutics Inc. is May 09, 2024.
Click to get the best stock tips daily for free!

About Abeona Therapeutics Inc.

Abeona Therapeutics. Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-associated virus (AAV)-based gene therapy for Sanfilippo syndrome type A; ABO-201 to treat CLN3 disease;... ABEO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT